Literature DB >> 9516657

Isoforms and levels of transferrin, antithrombin, alpha(1)-antitrypsin and thyroxine-binding globulin in 48 patients with carbohydrate-deficient glycoprotein syndrome type I.

H Stibler1, U Holzbach, B Kristiansson.   

Abstract

Carbohydrate-deficient glycoprotein syndrome type I (CDGS I) is an autosomal recessive disease with multiple organ manifestations. The diagnostic biochemical marker has been typical carbohydrate-deficient isoforms of transferrin (Tf). Many other glycoproteins in blood may show similar defects, but have not been systematically studied before. Forty-eight CDGS I patients and 22 controls were examined for total concentrations and isoform distribution of Tf, antithrombin (AT), alpha(1)-antitrypsin (alpha(1)-AT) and thyroxine-binding globulin (TBG), and for the level of carbohydrate-deficient transferrin (CDT). The absolute values varied with age. The most frequent persistent quantitative changes were reduced levels of AT (97%) and elevated CDT values (100%). Isoforms lacking one to eight of four to eight possible sialic acid residues were found in AT, TBG and Tf in all cases, with variable intensity and frequency, and in all except one patient in alpha(1)-AT. The isoform changes were most constant and pronounced in Tf. The other three glycoproteins showed more abnormal heterogeneity in the youngest than in the older patients. The results indicated that the biochemical defect stabilizes with age, and suggested partial hypoglycosylation rather than non-glycosylation of these glycoproteins. Analysis of Tf isoforms is still the safest diagnostic marker of CDGS I from full-term birth and over the ages.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9516657     DOI: 10.1080/00365519850186832

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  14 in total

Review 1.  New disorders in carbohydrate metabolism: congenital disorders of glycosylation and their impact on the endocrine system.

Authors:  Bradley S Miller; Hudson H Freeze
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

2.  [Dysmorphia and psychomotor retardation].

Authors:  T Struffert; E M Feldmann; O Schofer; W Reith
Journal:  Radiologe       Date:  2005-03       Impact factor: 0.635

3.  Investigating diversity in human plasma proteins.

Authors:  Dobrin Nedelkov; Urban A Kiernan; Eric E Niederkofler; Kemmons A Tubbs; Randall W Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-25       Impact factor: 11.205

4.  Dolichol phosphate mannose synthase (DPM1) mutations define congenital disorder of glycosylation Ie (CDG-Ie)

Authors:  S Kim; V Westphal; G Srikrishna; D P Mehta; S Peterson; J Filiano; P S Karnes; M C Patterson; H H Freeze
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

5.  Reduced heparan sulfate accumulation in enterocytes contributes to protein-losing enteropathy in a congenital disorder of glycosylation.

Authors:  V Westphal; S Murch; S Kim; G Srikrishna; B Winchester; R Day; H H Freeze
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

6.  Genotypes and phenotypes of patients in the UK with carbohydrate-deficient glycoprotein syndrome type 1.

Authors:  F Imtiaz; V Worthington; M Champion; C Beesley; J Charlwood; P Clayton; G Keir; N Mian; B Winchester
Journal:  J Inherit Metab Dis       Date:  2000-03       Impact factor: 4.982

7.  Preparation and investigation of bioactive transferrin-iron complexes formed with different synergistic anions.

Authors:  Judit Gálicza; Andrea Vargová; Viktor Sándor; Csongor Kálmán Orbán; Csaba Dezso András; Beáta Abrahám; Szabolcs Lányi; Ferenc Kilár
Journal:  Protein J       Date:  2012-01       Impact factor: 2.371

8.  Improvement of CDG diagnosis by combined examination of several glycoproteins.

Authors:  J Fang; V Peters; B Assmann; C Körner; G F Hoffmann
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

9.  Haptoglobin glycoforms in a case of carbohydrate-deficient glycoprotein syndrome.

Authors:  M Ferens-Sieczkowska; A Midro; B Mierzejewska-Iwanowska; K Zwierz; I Katnik-Prastowska
Journal:  Glycoconj J       Date:  1999-10       Impact factor: 2.916

Review 10.  Approach to the interpretation of unexpected laboratory results arising in the care of patients with inborn errors of metabolism (IEM).

Authors:  Andre Mattman; Murray Potter
Journal:  Rev Endocr Metab Disord       Date:  2018-03       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.